Becton Dickinson and Co (BDX) Stock Analysis
Verdict: HOLD
Robust FCF and recurring medical supply volume support post-spinoff recovery, but high leverage (4.13x Net Debt/EBITDA) caps upside.
Investment score: 56/100
Analysis as of
Is Becton Dickinson and Co stock worth reviewing? AI model thesis
The model evaluates BDX as a Hold at USD 181.97. High free cash flow yield (5.2%) and defensive recurring revenue are balanced by net debt of $18.33B (Net Debt/EBITDA 4.13x) and 14 insider sell transactions with zero buys.
7-factor investment score
- Valuation: 50/100 (weight 20%)
- Financial Health: 52/100 (weight 15%)
- Technical Momentum: 68/100 (weight 15%)
- Earnings Quality: 72/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 55/100 (weight 10%)
- Risk-Adjusted Return: 60/100 (weight 15%)
Becton Dickinson and Co opportunities and risks
What speaks for BDX
- Expansion in high-margin pharmacy robotics and automation platforms.
What speaks against BDX
- Elevated balance sheet debt and interest burden.
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| BDX | 54.8x | 2.4x | 17.0x | 46.1% | 4.5% | 5.2% |
| ABT | 32.5x | 3.7x | 20.3x | 56.8% | 11.6% | 5.0% |
| ISRG | 46.6x | 13.2x | 31.7x | 66.7% | 28.4% | 2.2% |
| SYK | 28.7x | 4.1x | 18.9x | 65.2% | 14.4% | 4.4% |
| BSX | 17.7x | 3.1x | 13.6x | 71.2% | 17.5% | 5.6% |
| EW | 50.6x | 7.8x | 31.5x | 78.0% | 15.4% | 2.8% |
| Peer median | 32.5x | 4.1x | 20.3x | 66.7% | 15.4% | 4.4% |
Frequently asked questions about Becton Dickinson and Co (BDX)
Is BDX stock a good investment?
The cached TradeMates AI model rates Becton Dickinson and Co as HOLD with an investment score of 56/100. The model evaluates BDX as a Hold at USD 181.97. High free cash flow yield (5.2%) and defensive recurring revenue are balanced by net debt of $18.33B (Net Debt/EBITDA 4.13x) and 14 insider sell transactions with zero buys. This is algorithmic model output, not personal investment advice.
Is BDX stock a buy?
The TradeMates model verdict for BDX is HOLD with an investment score of 56/100. Treat this as a model signal to review, not a personal buy recommendation.